Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Bayshore Pharmaceuticals

Bayshore Pharmaceuticals
2011 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of contract manufacturing services for pharmaceutical and nutraceutical market. The company specializes in the manufacturing of liquid dietary and vitamin supplements and offers various services including product inception, formulation, development, testing, distribution, packaging, portfolio commercialization, niche customer identification, and project management services, allowing clients to focus on what they do best.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Services
Other Industries
Pharmaceuticals
Drug Discovery
Parent Company
Ipca Laboratories
Primary Office
  • 1202 Tech Boulevard
  • Suite 107
  • Tampa, FL 33619
  • United States

Bayshore Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Bayshore Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Bayshore Pharmaceuticals Executive Team (2)

Name Title Board
Seat
Contact
Info
David Raiskin Chief Executive Officer
Richard Cunningham President & Chief Operating Officer